Join The Conversation!
https://bit.ly/SurfingNASHPodcast

NASH-TAG 2022 takes place in Deer Valley Utah and on-line from January 7-8, 2022. Join Surfing NASH to learn about the important and innovative drug development and basic science talks in the meeting.

Co-chair Stephen Harrison leads the panel through each of the sessions during the conference’s first morning. The session starts with Michael Charlton’s annual "Year in Review" talk, includes discussions on an array of drug classes and ends with a session on the biologic basis of NASH progression. He pauses at the end of his review of each session, thus leaving Steering Committee member Jörn Schattenberg and Surfers Louise Campbell and Roger Green to comment on favorite presentations, ask questions and place this information in the context of what we are learning elsewhere about Fatty Liver disease and the drugs that are being developed to treat it.

S2-E60.1 - Previewing NASH-TAG 2022 Sessions 1-3 -- Focus on Drug Development

Drug developers, investors, researchers, and corporate executives wrestle weekly to understand what is happening in commercial development of NASH medications. Hepatology researcher and Key Opinion Leader Stephen Harrison, M.D., C-suite veteran Peter Traber, M.D., and Forecasting and pricing guru Roger Green, M.B.A. discuss the issues affecting the evolving NASH market from their own unique perspectives on the Surfing the NASH Tsunami podcast.

S2-E60.1 - Previewing NASH-TAG 2022 Sessions 1-3 -- Focus on Drug Development

SurfingMASH